LE WE PMID CA
Neuroprotective agents1960Neuroprotektive Substanz

2 2 dimethoxydibenzoylmethane

3 hydroxymorphinan

AM251 ttCB1

AM404

Androgen (BASKET)

Apoptosis

Autophagy

BN82451

Brefeldin A

Citicoline

CNS (Stroke BASKET)

Complement system

Dantrolene ttRyR1 ttRyR3

delta 9 tetraydrocannabinol

Dextromethorphane

Dimemorfan

Docosahexaenoic acid

Endocannabinoid

Epilepsy (Excitotoxicity)

ERS UFR (Pharmacology)

Erythropoietin

Estrogen

Fatty acid amide hydrolase

Gacyclidine

GDNF

GLP1 Glucagon like peptide1

Glycine proline glutamate GPE

GSK3

Histone deacetylase

HSP27

IGF1

Inflammation (BASKET)

Ion channel (Acid sensitive)

Ischemia reperfusion

KATP

Ketogenic diet

Lipid mediators

Lithium

Magnesium sulfate

MANF Mesencephalic astrocyte derived neurotrophic factor

Melatonin

Minocycline

Mitochondria (BASKET)

Neuroglobin

Neuroprotectin D1

Neuroprotective agents

Neurosteroids

PACAP

PARP

Peptide histidine isoleucine

Progesterone

Proinsulin

Propofol

Receptor (Cannabinoid)

Receptor (Glutamate metabotropic)

Receptor (NMDA)

Receptor (P2Y)

Regeneration of tissues and other biologic structures

Resveratrol

SERM

Spine and spinal cord (Traumatology)

STAT3

Superoxide dismutase SOD

SUR

Thiazolidinediones

Toll like receptor

Triflusal

Uncoupling protein

Vasoactive intestinal peptide

Vinpocetine ethyl apovincaminate

2009  
1
The neurotrophic and neuroprotective effects of psychotropic agents.
[19877500] Dialogues Clin Neurosci 11(3): 333-48 (2009)
2007  
2
Neuroprotective effects of propofol in acute cerebral injury.
[17894649] CNS Drug Rev 13(3): 333-51 (2007)
2007  
3
Pharmacological properties of BN82451: a novel multitargeting neuroprotective agent.
[17894648] CNS Drug Rev 13(3): 317-32 (2007)
2001  
4
Gacyclidine: a new neuroprotective agent acting at the N-methyl-D-aspartate receptor.
[11474423] CNS Drug Rev 7(2): 172-98 (2001)
2007  
5
Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain.
[17047683] J Cereb Blood Flow Metab 27(6): 1108-28 (2007)
2002  
6
Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades.
[11973422] J Cereb Blood Flow Metab 22(5): 503-14 (2002)
2001  
7
Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs.
[11524608] J Cereb Blood Flow Metab 21(9): 1013-33 (2001)
2000  
8
Estrogen as a neuroprotectant in stroke.
[10779008] J Cereb Blood Flow Metab 20(4): 631-52 (2000)
2009  
9
Neuroprotective role of mitochondrial uncoupling protein 2 in cerebral stroke.
[19240738] J Cereb Blood Flow Metab 29(6): 1069-78 (2009)
2003  
10
Novel mechanisms and approaches in the study of neurodegeneration and neuroprotection. a review.
[14715440] Neurotox Res 5(6): 375-83 (2003)
1990  
11
Brain protection: physiological and pharmacological considerations. Part II: The pharmacology of brain protection.
[2225293] Can J Anaesth 37(7): 762-77 (1990)
2006  
12
Triflusal: an antiplatelet drug with a neuroprotective effect?
[16939630] Cardiovasc Drug Rev 24(1): 11-24 (2006)
2008  
13
Progesterone for the treatment of experimental brain injury; a systematic review.
[17715141] Brain 131(Pt 2): 318-28 (2008)
2002  
14
Neuroprotective effects of antidepressant and mood stabilizing drugs.
[11836978] J Psychiatry Neurosci 27(1): 8-9 (2002)
2004  
15
Neuroprotection and acute spinal cord injury: a reappraisal.
[15717009] NeuroRx 1(1): 80-100 (2004)
2004  
16
Critical appraisal of neuroprotection trials in head injury: what have we learned?
[15717008] NeuroRx 1(1): 71-9 (2004)
2004  
17
Mechanisms of neural cell death: implications for development of neuroprotective treatment strategies.
[15717003] NeuroRx 1(1): 5-16 (2004)
2009  
18
Current status of neuroprotection for cerebral ischemia: synoptic overview.
[19064810] Stroke 40(3 Suppl): S111-4 (2009)
2001  
19
Neuronal cell death in nervous system development, disease, and injury (Review).
[11295106] Int J Mol Med 7(5): 455-78 (2001)
2010  
20
Novel neuroprotective strategies in ischemic retinal lesions.
[20386654] Int J Mol Sci 11(2): 544-61 (2010)
2009  
21
Unconventional neurotransmitters, neurodegeneration and neuroprotection.
[19219299] Braz J Med Biol Res 42(1): 68-75 (2009)
2004  
22
The search for neuroprotective strategies in stroke.
[14970016] AJNR Am J Neuroradiol 25(2): 181-94 (2004)
2010  
23
Mitochondrial mechanisms of estrogen neuroprotection.
[19931595] Biochim Biophys Acta 1800(10): 1113-20 (2010)
2007  
24
Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system.
[17431228] Endocr Rev 28(4): 387-439 (2007)
2008  
25
Mitochondria, oxidative stress and PARP-1 network: a new target for neuroprotective effects of tetracyclines?
[18372301] J Physiol 586(10): 2427-8 (2008)
2011  
26
Neuropsychotoxic and neuroprotective potentials of dextromethorphan and its analogs.
[21606622] J Pharmacol Sci 116(2): 137-48 (2011)
2008  
27
Neuropsychotoxicity of abused drugs: potential of dextromethorphan and novel neuroprotective analogs of dextromethorphan with improved safety profiles in terms of abuse and neuroprotective effects.
[18198471] J Pharmacol Sci 106(1): 22-7 (2008)
2010  
28
The endocannabinoid system as a target for the treatment of neurodegenerative disease.
[20590559] Br J Pharmacol 160(3): 480-98 (2010)
2010  
29
Glucagon-like peptide 1 receptor stimulation as a means of neuroprotection.
[20128800] Br J Pharmacol 159(3): 495-501 (2010)
2009  
30
IGF-1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions.
[19438508] Br J Pharmacol 157(6): 881-91 (2009)
2008  
31
Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly.
[18059324] Br J Pharmacol 153 Suppl 1(-): S325-38 (2008)
2006  
32
Endogenous neuroprotective factors: neurosteroids.
[16845207] Pharmacol Rep 58(3): 335-40 (2006)
2011  
33
Role of vinpocetine in cerebrovascular diseases.
[21857073] Pharmacol Rep 63(3): 618-28 (2011)
2005  
34
Neuroprotective potential of three neuropeptides PACAP, VIP and PHI.
[15985713] Pharmacol Rep 57(3): 307-20 (2005)
2011  
35
The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's disease.
[21340000] Int J Mol Sci 12(1): 506-69 (2011)
2008  
36
Estrogens and progesterone as neuroprotectants: what animal models teach us.
[17981614] Front Biosci 13(-): 1083-9 (2008)
2011  
37
Histone deacetylase inhibitors as therapeutic agents for acute central nervous system injuries.
[21274503] Mol Med 17(5-6): 448-56 (2011)
2009  
38
The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies.
[18845187] Brain Res Rev 59(2): 293-315 (2009)
2008  
39
Progesterone exerts neuroprotective effects after brain injury.
[17826842] Brain Res Rev 57(2): 386-97 (2008)
2008  
40
Drugs acting on SUR1 to treat CNS ischemia and trauma.
[18032110] Curr Opin Pharmacol 8(1): 42-9 (2008)
2008  
41
Acid-sensing ion channels (ASICs) as pharmacological targets for neurodegenerative diseases.
[17945532] Curr Opin Pharmacol 8(1): 25-32 (2008)
2008  
42
Neuroglobin: an endogenous neuroprotectant.
[17942367] Curr Opin Pharmacol 8(1): 20-4 (2008)
2007  
43
A dibenzoylmethane derivative protects dopaminergic neurons against both oxidative stress and endoplasmic reticulum stress.
[17913843] Am J Physiol Cell Physiol 293(6): C1884-94 (2007)
2010  
44
Widespread cortical expression of MANF by AAV serotype 7: localization and protection against ischemic brain injury.
[20685313] Exp Neurol 225(1): 104-13 (2010)
2010  
45
Prospects for minocycline neuroprotection.
[20697034] Arch Neurol 67(12): 1442-8 (2010)
2007  
46
Neuroprotection: challenges and opportunities.
[17562927] Arch Neurol 64(6): 794-800 (2007)
2007  
47
Delta9-tetrahydrocannabinol (THC) and AM 404 protect against cerebral ischaemia in gerbils through a mechanism involving cannabinoid and opioid receptors.
[17965746] Br J Pharmacol 152(8): 1301-11 (2007)
2011  
48
A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury.
[20146558] J Neurotrauma 28(8): 1545-88 (2011)
2010  
49
Neurotoxins: free radical mechanisms and melatonin protection.
[21358970] Curr Neuropharmacol 8(3): 194-210 (2010)
2008  
50
Clearing the brain's cobwebs: the role of autophagy in neuroprotection.
[19305790] Curr Neuropharmacol 6(2): 97-101 (2008)
2010  
51
Resveratrol as a therapeutic agent for neurodegenerative diseases.
[20306310] Mol Neurobiol 41(2-3): 375-83 (2010)
2010  
52
Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection.
[20157789] Mol Neurobiol 41(2-3): 172-9 (2010)
2011  
53
Neuroprotection by spice-derived nutraceuticals: you are what you eat!
[21360003] Mol Neurobiol 44(2): 142-59 (2011)
2010  
54
P2Y2 nucleotide receptor-mediated responses in brain cells.
[20387013] Mol Neurobiol 41(2-3): 356-66 (2010)
2009  
55
Multiple roles of HDAC inhibition in neurodegenerative conditions.
[19775759] Trends Neurosci 32(11): 591-601 (2009)
2010  
56
Erythropoietin for infants with hypoxic-ischemic encephalopathy.
[20090525] Curr Opin Pediatr 22(2): 139-45 (2010)
2008  
57
Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration.
[19145989] Rev Neurosci 19(4-5): 341-61 (2008)
2011  
58
Citicoline: pharmacological and clinical review, 2010 update.
[21432836] Rev Neurol 52 Suppl 2(-): S1-S62 (2011)
2011  
59
Magnesium sulphate for fetal neuroprotection.
[21877014] Rev Bras Ginecol Obstet 33(6): 265-70 (2011)
2010  
60
Potential future neuroprotective therapies for neurodegenerative disorders and stroke.
[20176298] Clin Geriatr Med 26(1): 125-47 (2010)
2009  
61
Dantrolene: mechanisms of neuroprotection and possible clinical applications in the neurointensive care unit.
[18696266] Neurocrit Care 10(1): 103-15 (2009)
2008  
62
Recent trends in erythropoietin-mediated neuroprotection.
[17936539] Int J Dev Neurosci 26(1): 103-11 (2008)
2008  
63
Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies.
[18396368] Prog Neurobiol 85(2): 194-213 (2008)
2011  
64
Proinsulin: from hormonal precursor to neuroprotective factor.
[21949502] Front Mol Neurosci 4(-): 20 (2011)
2009  
65
Neuroprotective actions of androgens on motoneurons.
[19393684] Front Neuroendocrinol 30(2): 130-41 (2009)
2010  
66
Benefits of histone deacetylase inhibitors for acute brain injury: a systematic review of animal studies.
[20831615] J Neurochem 115(4): 806-13 (2010)
2010  
67
Administration of thiazolidinediones for neuroprotection in ischemic stroke: a pre-clinical systematic review.
[20964688] J Neurochem 115(4): 845-53 (2010)
2007  
68
In search of the Holy Grail for the treatment of neurodegenerative disorders: has a simple cation been overlooked?
[17572175] Biol Psychiatry 62(1): 4-6 (2007)
2011  
69
GDNF and protection of adult central catecholaminergic neurons.
[21357726] J Mol Endocrinol 46(3): R83-92 (2011)
2011  
70
Selective estrogen receptor modulators as brain therapeutic agents.
[21071476] J Mol Endocrinol 46(1): R1-9 (2011)
2010  
71
Complement in neuroprotection and neurodegeneration.
[20116331] Trends Mol Med 16(2): 69-76 (2010)
2009  
72
HSP27: mechanisms of cellular protection against neuronal injury.
[19860665] Curr Mol Med 9(7): 863-72 (2009)
2010  
73
Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality.
[19527737] Life Sci 86(15-16): 615-23 (2010)
2007  
74
Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications.
[17379265] Steroids 72(5): 381-405 (2007)
2010  
75
2009  
76
Neuroprotective strategies targeting apoptotic and necrotic cell death for stroke.
[19137430] Apoptosis 14(4): 469-77 (2009)
2010  
77
Control of intracellular calcium signaling as a neuroprotective strategy.
[20335972] Molecules 15(3): 1168-95 (2010)
2011  
78
Neuroprotective actions of estradiol and novel estrogen analogs in ischemia: translational implications.
[21163293] Front Neuroendocrinol 32(3): 336-52 (2011)
2011  
79
Neuroprotection and recovery: recent data at the bench on citicoline.
[21164125] Stroke 42(1 Suppl): S33-5 (2011)
2011  
80
Citicoline in vascular cognitive impairment and vascular dementia after stroke.
[21164117] Stroke 42(1 Suppl): S40-3 (2011)
2011  
81
New approaches to neuroprotective drug development.
[21164111] Stroke 42(1 Suppl): S24-7 (2011)
2010  
82
Toll-like receptor tolerance as a mechanism for neuroprotection.
[21339866] Transl Stroke Res 1(4): 252-260 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.



Search PubMed and many other databases on the combined search terms

GG: neuroprotective
GG: neuroprotection

  • Neuroprotektive Substanz

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia